Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
PMV Pharmaceuticals prices IPO at $18 per share
PMV Pharmaceuticals announced pricing its initial public offering of 11.765 million common shares at $18 per share. The company said the shares were to begin trading on Nasdaq Global Select Market on September 25, 2020, and expected the offering to close on September 29, 2020.
2019
PMV Pharma completes $62 million Series C financing
PMV Pharmaceuticals announced completion of a $62 million Series C financing round led by Nextech Invest, with participation from other new and existing investors. The proceeds will support development of the company's p53 drug candidates.